| Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma Y Zhao, J Cao, A Melamed, M Worley, A Gockley, D Jones, HT Nia, ... Proceedings of the National Academy of Sciences 116 (6), 2210-2219, 2019 | 212 | 2019 |
| Phase II study of avelumab in patients with mismatch repair deficient and mismatch repair proficient recurrent/persistent endometrial cancer PA Konstantinopoulos, W Luo, JF Liu, DC Gulhan, C Krasner, JJ Ishizuka, ... Journal of Clinical Oncology 37 (30), 2786-2794, 2019 | 204 | 2019 |
| Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer A Gockley, A Melamed, AJ Bregar, JT Clemmer, M Birrer, JO Schorge, ... Obstetrics & Gynecology 129 (3), 439-447, 2017 | 137 | 2017 |
| Overall survival following neoadjuvant chemotherapy vs primary cytoreductive surgery in women with epithelial ovarian cancer: analysis of the National Cancer Database JA Rauh-Hain, A Melamed, A Wright, A Gockley, JT Clemmer, JO Schorge, ... JAMA oncology 3 (1), 76-82, 2017 | 106 | 2017 |
| Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy E Diver, E Hinchcliff, A Gockley, A Melamed, L Contrino, S Feldman, ... Journal of minimally invasive gynecology 24 (3), 402-406, 2017 | 105 | 2017 |
| Uterine leiomyosarcoma: a review article AA Gockley, JA Rauh-Hain, MG Del Carmen International Journal of Gynecologic Cancer 24 (9), 2014 | 76 | 2014 |
| The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy AA Gockley, A Melamed, NT Joseph, M Clapp, SY Sun, DP Goldstein, ... Gynecologic oncology 140 (3), 470-473, 2016 | 58 | 2016 |
| All-cause mortality after fertility-sparing surgery for stage I epithelial ovarian cancer A Melamed, AE Rizzo, R Nitecki, AA Gockley, AJ Bregar, JO Schorge, ... Obstetrics & Gynecology 130 (1), 71-79, 2017 | 55 | 2017 |
| Clinical presentation of complete hydatidiform mole and partial hydatidiform mole at a regional trophoblastic disease center in the United States over the past 2 decades SY Sun, A Melamed, NT Joseph, AA Gockley, DP Goldstein, ... International Journal of Gynecologic Cancer 26 (2), 2016 | 55 | 2016 |
| Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age A Melamed, AA Gockley, NT Joseph, SY Sun, MA Clapp, DP Goldstein, ... Gynecologic oncology 143 (1), 73-76, 2016 | 46 | 2016 |
| Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study A Melamed, G Fink, AA Wright, NL Keating, AA Gockley, MG Del Carmen, ... bmj 360, 2018 | 42 | 2018 |
| Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis … R Nitecki, A Melamed, AA Gockley, J Floyd, KJ Krause, RL Coleman, ... Gynecologic oncology 161 (3), 653-659, 2021 | 36 | 2021 |
| Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer A Gockley, A Melamed, A Cronin, MA Bookman, RA Burger, MC Cristae, ... American journal of obstetrics and gynecology 221 (6), 625. e1-625. e14, 2019 | 31 | 2019 |
| A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome BL Manning-Geist, K Hicks-Courant, AA Gockley, RM Clark, ... American Journal of Obstetrics and Gynecology 221 (4), 326. e1-326. e7, 2019 | 31 | 2019 |
| Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care … AA Gockley, NT Joseph, A Melamed, SY Sun, B Goodwin, M Bernstein, ... American Journal of Obstetrics and Gynecology 215 (3), 334. e1-334. e6, 2016 | 30 | 2016 |
| Association between overall survival and the tendency for cancer programs to administer neoadjuvant chemotherapy for patients with advanced ovarian cancer A Melamed, JA Rauh-Hain, AA Gockley, R Nitecki, PT Ramirez, ... JAMA oncology 7 (12), 1782-1790, 2021 | 29 | 2021 |
| Evaluation of treatment with talazoparib and avelumab in patients with recurrent mismatch repair proficient endometrial cancer PA Konstantinopoulos, AA Gockley, N Xiong, C Krasner, N Horowitz, ... JAMA oncology 8 (9), 1317-1322, 2022 | 27 | 2022 |
| Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old EJ Diver, EM Hinchcliff, AA Gockley, A Melamed, L Contrino, S Feldman, ... Journal of geriatric oncology 9 (5), 516-519, 2018 | 27 | 2018 |
| Moving beyond “complete surgical resection” and “optimal”: Is low-volume residual disease another option for primary debulking surgery? BL Manning-Geist, K Hicks-Courant, AA Gockley, RM Clark, ... Gynecologic oncology 150 (2), 233-238, 2018 | 27 | 2018 |
| The Wertheim hysterectomy: Development, modifications, and impact in the present day AL Swailes, A Gockley, R Phaëton, JP Kesterson Gynecologic oncology 145 (1), 3-8, 2017 | 24 | 2017 |
Alexander MelamedMass General Hospital / Harvard Medical School在 mgh.harvard.edu 的电子邮件经过验证
Alexander MelamedMass General Hospital / Harvard Medical School在 mgh.harvard.edu 的电子邮件经过验证
Alexi WrightAssociate Professor, Harvard Medical School在 dfci.harvard.edu 的电子邮件经过验证